Sequence Bio’s NL Genome Project is researching the genetic makeup of 10,000 volunteering participants in Newfoundland and Labrador. By studying our province’s one-of-a-kind DNA and health information, we hope to discover better, safer medicines and improve how we treat and prevent diseases.
Sequence Bio is committed to benefiting the lives of individuals, families, and communities in Newfoundland and Labrador for generations to come. We’ll share any discoveries from the NL Genome Project with researchers, policy makers, and doctors across the province, and return genetic findings to participants.
By working together, we believe that Newfoundlanders and Labradorians can change lives at home and around the world.
Modern drug discovery relies on the right kind of information: real-world patient data that integrates pan-omics with well-characterized phenotypic information. And while this information isn't found everywhere, it is found in Newfoundland and Labrador.
We're always looking for exciting partnerships with companies that understand the value of human genetics as a platform for drug discovery and are willing to share our commitment to the people of Newfoundland and Labrador, so get in touch today!
We're a committed team of Newfoundlanders and Labradorians and global experts from a wide range of backgrounds, driven to change the future of healthcare and accelerate the discovery of better, safer medicines and disease treatments. Get to know us a little more by clicking on our photos!
We're hiring, join the team
Sequence Bio is conducting research in Newfoundland and Labrador, and doing so in an ethical way is our first priority. Our research efforts require approval by the Health Research Ethics Board (HREB), and the words “believe,” “expect,” “anticipate,” and similar expressions, among others, generally identify our intent and/or objective to undertake additional research in this province.
Sequence Bio does not share information about planned research studies until they are approved.